Khosla Ventures

Khosla Ventures is a California-based venture capital firm founded in 2004 by Vinod Khosla. It provides capital and strategic guidance to startups across stages, focusing on technology-driven companies in areas such as artificial intelligence, climate and sustainability, enterprise software and services, fintech, digital health, medical technology and diagnostics, therapeutics, consumer products, and frontier technologies. The firm backs bold ventures with the potential to disrupt markets and improve lives, supporting companies from early to growth stages and working closely with entrepreneurs to apply science, technology and innovative business models. While primarily investing in North American technology companies, Khosla Ventures pursues opportunities globally and emphasizes experimentation and impact alongside financial returns. The firm also maintains related impact initiatives that support entrepreneurs addressing socio-economic challenges in emerging markets.

Alex Bentley

Partner and Investor

Ryno Blignaut

Operating Partner

Alice Brooks

Partner

Peter Buckland JD

COO, Partner, and Managing Director

Brian Byun

Venture Partner

Catherine Casuga

Operating Partner

Jon Chu

Partner

Adam Coates Ph.D

Operating Partner

Ardy Daie

Operating Partner

Bryan Gartner

Partner

Kanu Gulati

Partner

Kanupriya Gulati Ph.D

Partner and Investor

Judy Huang

Operating Partner

Jun Jeon

Principal

Samir Kaul

Founding General Partner

Vinod Khosla

Managing Director

Kelly Kinnard

Operating Partner

Alex Morgan

Partner

Nabeel Quryshi

Associate

Arash Rebek JD

Partner, Capital Formation

Jessy Rivest

Partner

Jai Sajnani

Partner

Leah Scanlan

Operating Partner

Nikita Shamgunov

Partner

Sven Strohband

Managing Director

Rajesh Swaminathan

Partner and Investor

Adina Tecklu

Partner

David Weiden

Partner

Reze Wong

Partner

Ece Erdagoz Wyrick

Principal

Past deals in Infants

Vitara Biomedical

Series B in 2024
Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.

Vitara Biomedical

Series B in 2022
Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.

Embrace Global

Series A in 2013
Embrace Innovations is a Bengaluru-based healthcare technology company focused on developing innovative and affordable medical devices for emerging markets. The company specializes in creating solutions to improve maternal and child health, notably through its flagship product, the Embrace Nest, a portable infant warmer designed for low birth-weight and premature babies. This device offers a cost-effective alternative to conventional incubators, priced at less than 1% of typical incubator solutions, aiming to reduce the high mortality rate among premature infants. In addition to its existing products, Embrace conducts research and development to foster new low-cost healthcare innovations, addressing critical needs in underserved communities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.